Stock Earnings

Question 1

What are Unicycive Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Unicycive Therapeutics Inc has a total asset of $31, Net loss of $-37

Question 2

What are the key financial ratios for UNCY?

Accepted Answer

Unicycive Therapeutics Inc's Current ratio is 1.29, has a Net margin is 0, sales per share of $0.

Question 3

How is Unicycive Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Unicycive Therapeutics Inc largest revenue segment is Novel Therapies, at a revenue of 675,000 in the most earnings release.For geography, United States is the primary market for Unicycive Therapeutics Inc, at a revenue of 675,000.

Question 4

Is Unicycive Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Unicycive Therapeutics Inc has a net loss of $-37

Question 5

Does Unicycive Therapeutics Inc have any liabilities?

Accepted Answer

yes, Unicycive Therapeutics Inc has liability of 24

Question 6

How many outstanding shares for Unicycive Therapeutics Inc?

Accepted Answer

Unicycive Therapeutics Inc has a total outstanding shares of 11.38

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	--	12	8	6	2	1
Research & Development	--	20	12	12	6	1
Operating Expenses	--	32	21	19	8	2
Other Non Operating Income (Expenses)	--	-5	-10	0	0	0
Pretax Income	--	-36	-30	-18	-10	-2
Income Tax Expense	--	--	--	--	--	--
Net Income	--	-37	-31	-18	-10	-2
Net Income Growth	--	19%	72%	80%	400%	0%
Shares Outstanding (Diluted)	--	6.69	2.45	1.5	1.49	1.44
Shares Change (YoY)	--	173%	63%	0%	3%	0%
EPS (Diluted)	--	-5.64	-12.8	-11.99	-6.68	-1.55
EPS Growth	--	-56%	7%	79%	331%	4%
Free Cash Flow	-29	-28	-18	-15	-5	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	--	0%	0%	0%	0%	0%
Profit Margin	--	0%	0%	0%	0%	0%
Free Cash Flow Margin	--	0%	0%	0%	0%	0%
EBITDA	--	-32	-20	-18	-8	--
EBITDA Margin	--	0%	0%	0%	0%	--
D&A For EBITDA	0	0	0	0	0	--
EBIT	--	-32	-20	-18	-8	-2
EBIT Margin	--	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Unicycive Therapeutics Inc (UNCY) Financial

UNCY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is UNCY?

UNCY Income

Follow-Up Questions